The transformation of adult but not newborn human lymphocytes by Epstein Barr virus and phytohemagglutinin is inhibited by interferon: the early suppression by T cells of Epstein Barr infection is mediated by interferon
- PMID: 6161964
The transformation of adult but not newborn human lymphocytes by Epstein Barr virus and phytohemagglutinin is inhibited by interferon: the early suppression by T cells of Epstein Barr infection is mediated by interferon
Abstract
In a previous study, it was demonstrated that T cells from adult individuals were able to suppress the transformation of B cells after infection by EBV. In this paper, it is shown that this suppression is mediated by interferon. Thus, the suppression is abrogated by anti-interferon serum and mimicked by human leukocyte interferon. Furthermore, the interferon is released in response to the virus-infected B cell, not the virus alone. The relevance of these results to previous clinical evidence, indicating a role for interferon in recovery from EBV infection, is discussed. Interferon will also suppress the transformation of adult B lymphocytes by the mitogen phytohemagglutinin (PHA). However, interferon at concentrations 2 to 3 orders of magnitude higher was unable to suppress the transformation of neonatal B lymphocytes by either EBV or PHA. These experiments suggest that EBV and PHA induced transformation share a common interferon sensitive step. Lastly, the resistance of newborn lymphocytes to the protective effect of interferon may be an important consideration in the application of interferon as an antiviral or anti-tumor agent.
Similar articles
-
The suppression of Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cell.J Immunol. 1980 Feb;124(2):745-51. J Immunol. 1980. PMID: 6243331
-
T cell-mediated immunoregulation of Epstein Barr virus- (EBV) induced B lymphocyte activation in EBV-seropositive and EBV-seronegative individuals.J Immunol. 1982 Feb;128(2):575-9. J Immunol. 1982. PMID: 6274959
-
Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis).J Immunol. 1985 May;134(5):3082-8. J Immunol. 1985. PMID: 2984282
-
B cells under influence: transformation of B cells by Epstein-Barr virus.Nat Rev Immunol. 2003 Oct;3(10):801-12. doi: 10.1038/nri1201. Nat Rev Immunol. 2003. PMID: 14523386 Review.
-
Clinical and immunological considerations in Epstein-Barr virus-associated diseases.Scand J Infect Dis Suppl. 1996;100:72-82. Scand J Infect Dis Suppl. 1996. PMID: 8860357 Review.
Cited by
-
Effects of pure interferons on Epstein-Barr virus infection in vitro.J Virol. 1985 May;54(2):615-8. doi: 10.1128/JVI.54.2.615-618.1985. J Virol. 1985. PMID: 2580994 Free PMC article.
-
Epstein-Barr virus recombinants with specifically mutated BCRF1 genes.J Virol. 1993 Dec;67(12):7406-13. doi: 10.1128/JVI.67.12.7406-7413.1993. J Virol. 1993. PMID: 7693971 Free PMC article.
-
Cytotoxic mechanisms in vitro against Epstein-Barr virus infected lymphoblastoid cell lines in rheumatoid arthritis.Ann Rheum Dis. 1986 Jul;45(7):546-52. doi: 10.1136/ard.45.7.546. Ann Rheum Dis. 1986. PMID: 3017244 Free PMC article.
-
Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement.J Clin Invest. 1982 Nov;70(5):1081-91. doi: 10.1172/jci110696. J Clin Invest. 1982. PMID: 6290536 Free PMC article.
-
An Epstein-Barr virus immortalization associated gene segment interferes specifically with the IFN-induced anti-proliferative response in human B-lymphoid cell lines.EMBO J. 1990 Jan;9(1):147-52. doi: 10.1002/j.1460-2075.1990.tb08090.x. EMBO J. 1990. PMID: 2153074 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical